ProForma 2.0
validated simple linear
KKLFKKILRYLNH
BP203
Aliases: BP203, BP607
Normalized sequence
KKLFKKILRYLNH
13 amino acids
Release PepDiana-V1-20260620
125
Activity records
2
Source papers
124
Positive
1
Negative / threshold
Versioned scientific descriptors
No separate physicochemical property was reported in the primary-literature identity record. PepDiana release values are shown as computed properties.
Molecular weight
1701.1095 Da
Molecular formula
C82H137N23O16
Theoretical pI
10.5828
Net charge at pH 7
4.8423
GRAVY
-0.7231
Instability index
8.4385
Aromaticity
0.1538
Topological polar surface area
670.5 Ų
cLogP
-1.7882
Hydrogen-bond donors
24
Hydrogen-bond acceptors
22
Rotatable bonds
61
Method: PepDiana sequence/structure descriptor pipeline
Tool: Biopython+RDKit · Biopython 1.85; RDKit 2024.09.6
Calculated: 2026-06-20T11:01:38.358971+00:00
Assumptions: ph=7; termini=free N-terminus and free C-terminus for simple linear peptides; stereochemistry=standard L-amino acids; smiles_length_limit=200
ProForma 2.0
validated simple linear
KKLFKKILRYLNH
HELM 2.0
validated simple linear
PEPTIDE1{K.K.L.F.K.K.I.L.R.Y.L.N.H}$$$$V2.0
Canonical SMILES
validated
CCC(C)C(NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(Cc1ccccc1)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(N)CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(=O)NC(Cc1c[nH]cn1)C(=O)O
Isomeric SMILES
validated
CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O
Paper-level observations
Table 2: E. coli ATCC 25922, BP203 MIC 4 μg/mL
Table 2: E. coli ATCC 25922, BP203 MBC 4 μg/mL
Table 2: K. pneumoniae ATCC BAA-1706, BP203 MIC 4 μg/mL
Table 2: K. pneumoniae ATCC BAA-1706, BP203 MBC 4 μg/mL
Table 2: EC-01, BP203 MIC 2 μg/mL
Table 2: EC-01, BP203 MBC 2 μg/mL
Table 2: EC-02, BP203 MIC 8 μg/mL
Table 2: EC-02, BP203 MBC 8 μg/mL
Table 2: EC-03, BP203 MIC 2 μg/mL
Table 2: EC-03, BP203 MBC 2 μg/mL
Table 2: EC-04, BP203 MIC 2 μg/mL
Table 2: EC-04, BP203 MBC 4 μg/mL
Table 2: EC-05, BP203 MIC 8 μg/mL
Table 2: EC-05, BP203 MBC 8 μg/mL
Table 2: EC-06, BP203 MIC 2 μg/mL
Table 2: EC-06, BP203 MBC 2 μg/mL
Table 2: EC-07, BP203 MIC 8 μg/mL
Table 2: EC-07, BP203 MBC 8 μg/mL
Table 2: EC-08, BP203 MIC 16 μg/mL
Table 2: EC-08, BP203 MBC 16 μg/mL
Table 2: EC-09, BP203 MIC 2 μg/mL
Table 2: EC-09, BP203 MBC 2 μg/mL
Table 2: EC-10, BP203 MIC 8 μg/mL
Table 2: EC-10, BP203 MBC 8 μg/mL
Table 2: KP-01, BP203 MIC 16 μg/mL
Table 2: KP-01, BP203 MBC 16 μg/mL
Table 2: KP-02, BP203 MIC 256 μg/mL
Table 2: KP-02, BP203 MBC 256 μg/mL
Table 2: KP-03, BP203 MIC 128 μg/mL
Table 2: KP-03, BP203 MBC 128 μg/mL
Table 2: KP-04, BP203 MIC 512 μg/mL
Table 2: KP-04, BP203 MBC 512 μg/mL
Table 2: KP-05, BP203 MIC 32 μg/mL
Table 2: KP-05, BP203 MBC 32 μg/mL
Table 2: KP-06, BP203 MIC 256 μg/mL
Table 2: KP-06, BP203 MBC 256 μg/mL
Table 2: KP-07, BP203 MIC 128 μg/mL
Table 2: KP-07, BP203 MBC 128 μg/mL
Table 2: KP-08, BP203 MIC 256 μg/mL
Table 2: KP-08, BP203 MBC 256 μg/mL
Table 2: KP-09, BP203 MIC 512 μg/mL
Table 2: KP-09, BP203 MBC 512 μg/mL
Table 2: KP-10, BP203 MIC 512 μg/mL
Table 2: KP-10, BP203 MBC 512 μg/mL
Table 3: E. coli ATCC 25922, 25°C control, BP203 MIC 4 μg/mL
Table 3: E. coli ATCC 25922, 37°C, BP203 MIC 4 μg/mL
Table 3: E. coli ATCC 25922, 50°C, BP203 MIC 4 μg/mL
Table 3: E. coli ATCC 25922, 70°C, BP203 MIC 4 μg/mL
Table 3: E. coli ATCC 25922, 90°C, BP203 MIC 4 μg/mL
Table 3: K. pneumoniae ATCC BAA-1706, 25°C control, BP203 MIC 4 μg/mL
Table 3: K. pneumoniae ATCC BAA-1706, 37°C, BP203 MIC 4 μg/mL
Table 3: K. pneumoniae ATCC BAA-1706, 50°C, BP203 MIC 4 μg/mL
Table 3: K. pneumoniae ATCC BAA-1706, 70°C, BP203 MIC 4 μg/mL
Table 3: K. pneumoniae ATCC BAA-1706, 90°C, BP203 MIC 4 μg/mL
Table 4: E. coli ATCC 25922, pH 7 control, BP203 MIC 4 μg/mL
Table 4: E. coli ATCC 25922, pH 2, BP203 MIC 4 μg/mL
Table 4: E. coli ATCC 25922, pH 4, BP203 MIC 4 μg/mL
Table 4: E. coli ATCC 25922, pH 6, BP203 MIC 4 μg/mL
Table 4: E. coli ATCC 25922, pH 8, BP203 MIC 4 μg/mL
Table 4: E. coli ATCC 25922, pH 10, BP203 MIC 4 μg/mL
Table 4: K. pneumoniae ATCC BAA-1706, pH 7 control, BP203 MIC 4 μg/mL
Table 4: K. pneumoniae ATCC BAA-1706, pH 2, BP203 MIC 4 μg/mL
Table 4: K. pneumoniae ATCC BAA-1706, pH 4, BP203 MIC 4 μg/mL
Table 4: K. pneumoniae ATCC BAA-1706, pH 6, BP203 MIC 4 μg/mL
Table 4: K. pneumoniae ATCC BAA-1706, pH 8, BP203 MIC 4 μg/mL
Table 4: K. pneumoniae ATCC BAA-1706, pH 10, BP203 MIC 4 μg/mL
Table 5: E. coli ATCC 25922, 0% FBS control, BP203 MIC 4 μg/mL
Table 5: E. coli ATCC 25922, 25% FBS, BP203 MIC 4 μg/mL
Table 5: E. coli ATCC 25922, 50% FBS, BP203 MIC 8 μg/mL
Table 5: K. pneumoniae ATCC BAA-1706, 0% FBS control, BP203 MIC 4 μg/mL
Table 5: K. pneumoniae ATCC BAA-1706, 25% FBS, BP203 MIC 4 μg/mL
Table 5: K. pneumoniae ATCC BAA-1706, 50% FBS, BP203 MIC 4 μg/mL
Table 6: E. coli ATCC 25922, Control, BP203 MIC 4 μg/mL
Table 6: E. coli ATCC 25922, NaCl 100 mM, BP203 MIC 8 μg/mL
Table 6: E. coli ATCC 25922, NaCl 150 mM, BP203 MIC 16 μg/mL
Table 6: E. coli ATCC 25922, NaCl 200 mM, BP203 MIC 16 μg/mL
Table 6: E. coli ATCC 25922, MgCl2 0.5 mM, BP203 MIC 4 μg/mL
Table 6: E. coli ATCC 25922, MgCl2 1 mM, BP203 MIC 4 μg/mL
Table 6: E. coli ATCC 25922, MgCl2 2 mM, BP203 MIC 8 μg/mL
Table 6: E. coli ATCC 25922, FeCl3 1 μM, BP203 MIC 4 μg/mL
Table 6: E. coli ATCC 25922, FeCl3 4 μM, BP203 MIC 4 μg/mL
Table 6: E. coli ATCC 25922, FeCl3 8 μM, BP203 MIC 4 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, Control, BP203 MIC 4 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, NaCl 100 mM, BP203 MIC 8 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, NaCl 150 mM, BP203 MIC 16 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, NaCl 200 mM, BP203 MIC 16 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, MgCl2 0.5 mM, BP203 MIC 4 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, MgCl2 1 mM, BP203 MIC 8 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, MgCl2 2 mM, BP203 MIC 8 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, FeCl3 1 μM, BP203 MIC 4 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, FeCl3 4 μM, BP203 MIC 8 μg/mL
Table 6: K. pneumoniae ATCC BAA-1706, FeCl3 8 μM, BP203 MIC 8 μg/mL
Table 3: BP607 MIC 50 µg/ml against S. aureus ATCC 29213
Table 3: BP607 MBC 50 µg/ml against S. aureus ATCC 29213
Table 3: BP607 MIC 50 µg/ml against S. aureus MRSA USA 300
Table 3: BP607 MBC 50 µg/ml against S. aureus MRSA USA 300
Table 3: BP607 MIC 25 µg/ml against P. aeruginosa ATCC 27853
Table 3: BP607 MBC 25 µg/ml against P. aeruginosa ATCC 27853
Table 3: BP607 MIC 50 µg/ml against P. aeruginosa ST175-1
Table 3: BP607 MBC 100 µg/ml against P. aeruginosa ST175-1
Table 3: BP607 MIC 3.13 µg/ml against A. baumannii ATCC 19606
Table 3: BP607 MBC 6.25 µg/ml against A. baumannii ATCC 19606
Table 3: BP607 MIC 25 µg/ml against A. baumannii IB010
Table 3: BP607 MBC 50 µg/ml against A. baumannii IB010
Table 3: BP607 MIC 6.25 µg/ml against A. baumannii Ab-1
Table 3: BP607 MBC 6.25 µg/ml against A. baumannii Ab-1
Table 3: BP607 MIC 12.5 µg/ml against K. pneumoniae ATCC 43816
Table 3: BP607 MBC 12.5 µg/ml against K. pneumoniae ATCC 43816
Table 3: BP607 MIC 12.5 µg/ml against K. pneumoniae CG258
Table 3: BP607 MBC 12.5 µg/ml against K. pneumoniae CG258
Table 3: BP607 MIC 6.25 µg/ml against E. coli ATCC 25922
Table 3: BP607 MBC 6.25 µg/ml against E. coli ATCC 25922
Table 3: BP607 MIC 12.5 µg/ml against E. coli ESBL 1057.1
Table 3: BP607 MBC 12.5 µg/ml against E. coli ESBL 1057.1
Section 3.3: BP607 was bactericidal at 2x MIC after 24h against K. pneumoniae CG258
Section 3.3: all three peptides were bactericidal for E. coli ESBL 1057.1 at 6 and 24h at MIC
Section 3.3: BP607 maintained bactericidal effect at 24h against K. pneumoniae CG258 at MIC
Section 3.3: none of the peptides were bactericidal for A. baumannii ATCC 19606 at 6h or 24h at MIC
Section 3.1: BP607 inhibited growth of all strains by ≈90% at 50 µg/ml
Section 3.5: BP607 was completely degraded after 10 min in human serum
Text: BP203 demonstrated negligible hemolysis even at concentrations as high as 200 μg/mL
Text: IC50 values for BP203 were >200 μg/mL against MRC-5
Text: BP203 reduced cell viability to 56.01% at 200 μg/mL
Table 1: BP607 hemolysis 42% at 150 µM (from Oddo et al., 2016)
Section 3.6: BP607 resulted in 80% mortality after 24h (Fig. 5B)
Citation and release provenance
Cite this identity as PepDiana record PEPDIA-PLP-001508, release PepDiana-V1-20260620. Experimental observations retain their paper, mention, and activity-record identifiers.
Record updated: 2026-06-22T07:14:26.229247+00:00